Joint Venture6 Feb 2025, 10:52 pm
Dr. Lal PathLabs Subsidiary Gets Green Light for Voluntary Liquidation, Business Consolidation
AI Summary
Dr. Lal PathLabs Ltd. has announced that the Extra-Ordinary General Meeting of its Wholly Owned Subsidiary, Suburban Diagnostics (India) Private Limited, held on February 6, 2025, has accorded approval for voluntary liquidation and expeditious consolidation of its business with the Company on a going concern basis, subject to compliance of applicable laws. This decision follows the in-principle approval given by the Board of Directors of Suburban in their meeting on January 30, 2025. The necessary disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 was submitted on January 30, 2025.
Key Highlights
- Suburban Diagnostics (India) Private Limited, a Wholly Owned Subsidiary of Dr. Lal PathLabs Ltd, has received approval for voluntary liquidation
- The business of Suburban will be consolidated with Dr. Lal PathLabs Ltd on a going concern basis
- The decision follows the in-principle approval given by the Board of Directors of Suburban in their meeting on January 30, 2025
- The necessary disclosure was submitted on January 30, 2025 as a part of initial disclosure
- The consolidation is subject to compliance of applicable laws